Human Immuno-deficiency Virus (HIV) Disease

1 clinical trials · Condition

Record	Firm	Date
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382 (NCT06032546)	AbbVie	2023-10-12

Every clearance here is in the API, with alerts when new ones post.